Intensity modulated particle therapy in raster scan method with protons and C12-ions: Inspire

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023443

Enrollment

300

Registered

2021-02-10

Start date

2021-03-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All possible, relevant ICDs should be included.

Interventions

Group 1: Within this registry study, patients (tumour diseases) are to be systematically followed up.

Eligibility

Sex/Gender

All

Age

10 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients = 18 years old, treatended with particle therapy at the MIT, written consent present to join the Inspire register trial

Exclusion criteria

Exclusion criteria: Since rare side effects and secondary malignancies in particular are also to be recorded, no specific exclusion criteria are envisaged.

Design outcomes

Primary

Measure	Time frame
-Systematic recording of toxicities (acute and late toxicities). -incidence of secondary malignancies	—

Countries

Germany

Contacts

Public ContactSebastian Adeberg

Klinik für Strahlentherapie und Radioonkologie Universitätsklinikum Gießen und Marburg GmbH Standort Marburg

sebastian.adeberg@uk-gm.de+49 (0) 6421/58-66434

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026